Form 4/A for BBIO BridgeBio Pharma, Inc.
Accepted 2025-01-08 00:00:00 ET · period of report 2024-12-26 · accession 0000950170-25-003541 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-01-08 | 2024-12-26 | BBIO | MCCORMICK FRANK | Dir | G - Gift | $0.00 | -7,400 | 112.7K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-26 | G | D | 7,400 | $0.00 | 112,686 | D | — | — |